Little is known about the predictors of eczema severity in the US population. Objectives: We sought to determine the distribution and associations of childhood eczema severity in the United States. Methods: We analyzed the data from the 2007 National Survey of Children's Health, a prospective questionnairebased study of a nationally representative sample of 91,642 children (range, 0Y17 years).
A topic dermatitis (AD) or eczema is a chronic inflammatory disorder of the skin that poses a significant public health burden. Several recent studies shed light on the epidemiology of eczema in the United States. A study of 102,353 children from the 2003 National Survey of Children's Health (NSCH) found that the US prevalence of childhood eczema is 10.7%. 1 A study of 27, 157 adults from the 2010 National Health Interview Survey found a 10.2% prevalence of eczema. 2 Although these studies help to define the disease prevalence, little is known about the distribution of disease severity in this population.
Although factors such as ethnicity, urban living, 1 and climatic factors 3 are known to influence disease risk, it is unclear what role factors such as these may play in determining disease severity. Mutations in the skin barrier gene filaggrin, while playing an important role in disease risk, have inconsistently been linked to disease severity. 4Y10 Understanding the factors driving disease severity is important because our previous work and the work of others revealed that disease severity directly correlates with the future risk for developing allergic comorbidities and asthma. 11, 12 In addition, children with severe disease are more likely to have a protracted disease course and a significantly worse quality of life compared with those with more mild disease. 11 Understanding the distribution and risk factors for disease severity may help identify opportunities to intervene in the hopes of improving the overall disease course. We aimed to determine the distribution and associated factors of childhood eczema severity in the United States using a large population-based cross-sectional database.
METHODS

National Survey of Children's Health
We used the data from the 2007 to 2008 NSCH survey of 91,642 households, which was designed to estimate the prevalence of various child health issues. National Survey of Children's Health was sponsored by the Maternal and Child Health Bureau and the US Department of Health and Human Services with a goal of more than 1700 households per state. The National Center for Health Statistics conducted the study using the State and Local Area Integrated Telephone Survey program. The telephone numbers were chosen at random, followed by identification of the households with 1 or more children younger than the age of 18 years and caregiver interview. Interviews were conducted in English, Spanish, and 4 Asian languages. Subsequently, caregivers were interviewed about a randomly selected child. The survey results were weighted by the NSCH to represent the population of noninstitutionalized children nationally and in each state. Using the data from US Census Bureau, sample weights were created that factored age, sex, race/ ethnicity, household size, and educational attainment of the most educated household member using a multistage area probability sampling design by the NSCH. These sample weights are needed to provide nationally representative prevalence estimates for each state's population of noninstitutionalized children younger than the age of 18 years as previously described. 13 All frequency data are presented as raw values, whereas the prevalence estimates that were presented reflect this complex weighting. The National Center for Health Statistics of Center for Diseases Control and Prevention oversaw sampling and telephone interviews. Approval by the institutional review board was waived.
Eczema Prevalence and Severity
Eczema and skin allergy prevalence was determined using the NSCH question, ''During the past 12 months, have you been told by a doctor or other health professional that (child) had eczema or any kind of skin allergy?'' This is referred to as eczema throughout the article. Because this question assessed the health careYdiagnosed eczema, we excluded all subjects who responded ''no'' or ''do not know'' to the question, ''During the past 12 months, did (child) see a doctor, nurse, or other health care professional for any kind of medical care, including sick-child care, well-child check-ups, physical exams, and hospitalizations?'' There were 91,642 children in the cohort; 79,667 of them had health care interaction in the previous year and were included in the final analysis. The severity of eczema was determined using the NSCH question, ''Would you describe (child's) eczema or skin allergy as mild, moderate, or severe?'' Responses were encoded as an ordinal variable, where 1 is equal to mild, 2 is equal to moderate, and 3 is equal to severe.
Associations With Eczema
A number of associations with eczema severity were examined, including age, sex, race/ethnicity, household income, family structure and size, highest level of maternal and paternal education, maternal and paternal birthplace, overall and mental health, primary language spoken in home, birthplace in the United States, residence in a metropolitan area, smokers living in the home, smoking in the home, dilapidated housing, presence of garbage on the street, and parks and sidewalks in the neighborhood. These covariates were selected for analysis based on a priori hypotheses and from the results of previous studies. 1, 2, 14 
Data Processing and Statistical Methods
All data processing and statistical analyses were performed in SAS version 9.2. The analyses of survey responses were performed using SURVEY procedures. Univariate associations were tested by Rao-Scott W 2 tests (SURVEYFREQ). Multivariate logistic regression models were constructed with eczema severity dichotomized into moderate to severe versus mild (SURVEYLOGISTIC). Models included predictors from bivariate analysis with P values of less than 0.05. This approach was used over ordinal logistic regressions because the data did not meet the proportional odds assumption (score test, P G 0.01) and for parsimony. All variables were tested in the model using backward and stepwise selection with the same results. There were no differences between these approaches. Significant explanatory variables included in the final models are presented. Adjusted odds ratios and 95% confidence intervals (95% CI) were estimated for each covariate. Complete data analysis was performed, that is, subjects with missing data were excluded. Correction for multiple dependent tests (k = 27) was performed by minimizing the false discovery rate with the approach of Benjamini and Hochberg 15 and yielded a critical P value of 0.026. Thus, uncorrected P values are presented, and P value less than 0.026 was considered to be statistically significant.
RESULTS
Eczema Prevalence and Severity
Eczema prevalence was 12.97% (95% CI, 12.42Y13.53). Overall, 67% (95% CI, 64.8Y69.2) of children with eczema reportedly had mild disease, 26.0% (95% CI, 23.9Y28.1) had moderate disease and 7.0% (95% CI, 5.8Y8.3) had severe disease (Table 1) . That is equivalent to 5.6, 2.2, and 0.6 million US children having mild, moderate, and severe disease, respectively.
There was a significant variation of the distribution of eczema severity nationwide (Rao-Scott W 2 , P = 0.004). The rates of severe eczema ranged from 2.0% to 12.9% across states and districts (Fig. 1 ). The highest rates of severe eczema occurred predominantly located in Mid-Atlantic and Midwestern states.
Univariate Analyses
Eczema severity was associated with older age (P = 0.0003) and African American and Hispanic race/ethnicity (P G 0.0001) but not with sex (P = 0.12; Table 2 ). Several household factors were associated with increased eczema severity, including lower household income (P G 0.0001), being the oldest child in the family (P = 0.02), and home with a single mother and no father present (P G 0.0001), but not with the number of children in the household (P = 0.03) or primary language spoken at home (P = 0.27).
Several parental factors were associated with more severe eczema, including paternal and maternal education level (P = 0.001 and G0.0001, respectively), maternal general health (P G 0.0001), and maternal and paternal emotional health (P G 0.0001 and 0.02, respectively). However, paternal, maternal, and child birthplace inside the United States were not associated with eczema severity (P Q 0.04).
Finally, several local environmental factors were associated with more severe eczema, including dilapidated housing (P = 0.0009) and garbage on the streets (P = 0.001). However, eczema severity was not associated with residence in a metropolitan area (P = 0.26), smokers living at home (P = 0.03), indoor smoking (P = 0.29), or the presence of a park (P = 0.53) or sidewalk (P = 0.94) in the neighborhood (Table 3) .
Multivariate Analysis
Multivariate survey logistic regression models were constructed using backward and stepwise selection from all significant variables from univariate analyses. Moderate-to-severe eczema was associated with older age (adjusted odds ratio [95% CI], P value; 
DISCUSSION
Using a population-based sample, we present the distribution and associations of eczema severity in the United States. The findings of this study suggest a multifactorial role of genetic, environmental, and lifestyle factors on eczema severity. First, we found significant statewide variation of eczema severity, with severe eczema occurring predominantly in Mid-Atlantic and Midwestern states. Furthermore, eczema severity was associated with household income, family structure, parental education and health, dilapidated housing, and the presence of garbage on local streets and inversely associated with birthplace in the United States. Previous international studies found only weak associations 5Y7,9,10 or no associations 4,8 between filaggrin mutations and AD severity. Together, these suggest that environmental and/or lifestyle factors drive disease severity in the United States and play a role at least as important as genetics.
The present study assessed the self-reported eczema severity over a 1-year period. This measure provides an overall assessment of eczema severity over a relatively broad period and is distinct from disease prevalence or incidence. This approach is quite useful because the assessment of eczema severity at a single time point may not capture the true disease severity, given the waxing and waning nature of the disease. We found that the distribution of eczema severity was 67% in mild, 26% in moderate, and 7% in severe. This is a slightly more severe disease distribution than the distribution of 82% in mild, 12% in moderate, and 6% in severe found in a previous study in the United Kingdom using a novel eczema severity score. 16 Another UK study using clinician assessment of severity found 84% in mild, 14% in moderate and 2% in severe. 17 The different distributions may reflect populationbased differences of eczema severity between the United States and United Kingdom. Alternatively, the caregiver report of AD severity may differ from that of the Nottingham Eczema Severity Score or clinician assessment used in those studies. 16, 17 Nevertheless, we previously demonstrated that the caregiver report of eczema severity strongly correlated with quality-of-life reporting and health care use in the United States. 12 Thus, the distribution of eczema severity found in this study seems to be a good indicator of the public health burden of eczema in the United States.
The distribution of eczema severity found in this study is also distinct from that of the distribution of US prevalence of eczema previously demonstrated, where peak prevalences occurred on the East coast and Pacific Northwest. 1 Many of the states with higher rates of severe eczema have large population densities with different racial/ethnic distributions, 18 more air pollution, 19 and colder climates. It is unknown what role, if any, these factors have on eczema severity. We previously found that climate conditions influence the prevalence of pediatric eczema in the United States, with the disease risk increasing in areas of lower relative humidity, lower UV index, lower temperatures, more precipitation, and increased days needing indoor heating. 3 The Northeastern states generally have lower UV index and relative humidity, which suggests that climate may influence the disease severity as well. It may be that low indoor humidity during the winter months in Northeastern and Midwestern states causes xerotic or irritant contact dermatitis in at-risk individuals, thereby predisposing to the development of eczema. Further studies are needed to determine whether climatic or other factors further drive eczema severity in the United States.
We found that severe eczema was associated with black race and Hispanic ethnicity. No studies have examined the role of racial/ethnic disparities in determining eczema severity. Previous studies found that eczema prevalence was higher in children of African descent compared with whites. 1,20Y22 Studies of racial/ ethnic disparities in asthma found that African Americans have significantly worse asthma outcomes, whereas Hispanics have lower quality of life secondary to asthma. 23 African American children are less likely to use preventive medications for asthma than white or Hispanic children 24 and are more likely to have lower health literacy. 23 Together, there seem to be significant racial/ ethnic disparities for AD and other allergic diseases.
Severe eczema was also associated with lower socioeconomic status, including lower household income, single-parent households, lower parental education, dilapidated housing, and garbage on the street. Hanifin and Reed 25 found that the US prevalence of AD and eczema decreased significantly with higher household income but did not compare AD severity by household income. However, Shaw et al 1 found that eczema prevalence in the United States increased with higher household incomes. Several other studies in the United States and internationally found that the markers of atopy such as skin prick test positivity and immunoglobulin E levels were increased with higher socioeconomic status. 26Y28 Future studies are needed to elucidate these points and to determine the cause(s) of racial/ethnic and perhaps socioeconomic disparities.
Eczema severity was significantly associated with being the oldest child in the household. This may be due to parental inexperience dealing with eczema skin care in their children, which would improve with subsequent children. This emphasizes the importance of education of parents about the proper use of emollients and medications by dermatologists and other providers. Alternatively, there may be different exposures in children with older siblings living in the home, such as earlier introduction of certain foods that might result in tolerance or greater exposure to allergens in the physical environment. Flohr et al 29 recently demonstrated increased sensitization to a variety of food allergens in children that were exclusively breast-fed, suggesting that sensitization occurs via transcutaneous sensitization. Family size and structure and household dietary and cultural practices may contribute to such transcutaneous sensitization. Future studies are needed to better understand the role of these factors on eczema. Moderate-to-severe eczema was also associated with older age, which remained significant in multivariate models. Previous studies found lower prevalence of childhood eczema and eczema with increasing age. 1, 12, 25 Together, these findings suggest that mild-to-moderate eczema generally becomes more quiescent with age and that children whose eczema persists are likely to have more severe disease. It is therefore important to study this group in the future to better understand the determinants of severe eczema in the population.
We found in multivariate models that birthplace outside the United States was associated with decreased eczema severity. This is consistent with previous studies of Silverberg et al 14 that showed children born outside the United States had significantly lower odds of atopic disease compared with those born in the United States, including asthma, eczema, hay fever, and food allergies. Interestingly, children born outside the United States who lived in the United States for more than 10 years when compared with only 0 to 2 years had significantly higher odds of developing eczema and other atopic disorders. Shaw et al 1 found that the prevalence of childhood eczema was lower in children who were born outside the United States or whose parents were born outside the United States. Similarly, Silverberg and Hanifin 2 found that the prevalence of eczema in US adults was lower in those born outside the United States compared with those born in the United States. Several other studies found that birthplace outside the United States was associated with lower prevalence of asthma. 30Y33 The results of this study suggest that birthplace outside the United States may also have a protective effect for eczema severity.
The strengths of this study include being large scale, US population based, and using backward and stepwise selection approaches in multivariate survey logistic regression models. However, the study also has some limitations. The NSCH question encompassed both eczema and skin allergies. We were therefore unable to distinguish between these 2 entities. However, the preponderant etiology of eczema in children is related to AD. It is possible that the responses are skewed by the inclusion of allergic or irritant contact dermatitis, which may increase with older age. However, this is less likely because the population that we have categorized as having eczema demonstrates disease prevalence, comorbidity profile, and a natural history course consistent with AD. 12 This group of children has a prevalence of eczema similar to 2 other studies of the prevalence of AD in the United States using more strict criteria. 34 A lower prevalence of affirmative responses to this question with age is consistent with the natural course of the disease. Lastly, children with a ''yes'' response to this question have a higher risk of asthma, food allergy, and hay fever with odds ratios very similar to previously published numbers for AD populations. History and severity of eczema were defined by the caregiver report. Previous studies using parental recall of history of physician-diagnosed eczema 34, 35 and severity of disease 36 have been validated and found to correlate well with physician examination. Moreover, the perception of severe eczema by parents and children is likely a better determinant of quality-of-life impairment and health care use than physician assessment. We reported that the caregiver report of severe eczema was associated with poorer overall health and greater health care use. 12 The caregiver report of severe eczema was associated with increased mental health comorbidity, including attention deficit hyperactivity disorder, depression, anxiety, conduct disorder, and autism. 37 Thus, the results of this survey-based approach using a patient-/caregiver-centered outcome are likely meaningful and accurate. The study is cross-sectional and therefore provides a snapshot view of eczema severity nationwide. Of course, eczema has a waxing and waning course, which may not be accurately represented in a cross-sectional study. However, the measure used in the study was the report of overall severity of eczema over a 1-year period, which better describes the variable disease course than the current severity. Nevertheless, future longitudinal studies are needed to identify risk factors for disease severity and flares.
In conclusion, childhood eczema severity varies widely nationwide and is associated with older age, African and Hispanic descent, and lower socioeconomic status. Future studies are needed to verify these associations and to further identify the environmental factors that drive eczema severity in the United States.
